Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BeamMed is a private medical device company focused on bone health diagnostics and related point-of-care screening solutions. The company develops, manufactures, and markets portable ultrasound-based bone density assessment systems used for early assessment, diagnosis, and monitoring of osteoporosis, with its Sunlight MiniOmni positioned as a handheld, radiation-free alternative for screening in clinics, physician offices, pharmacies, and other care settings. BeamMed states that its products are based on its patented Omnipath axial transmission technology and that thousands of devices are installed globally. In addition to bone health products, recent company materials also reference a handheld fundus camera with AI-enabled diabetic retinopathy screening capabilities. The business appears to operate from Israel with a U.S. commercial presence in Florida and remains privately held.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BeamMed.